Policy

Médicos como facilitadores, no tomadores de decisiones

Policy
Antonio Ciaglia, el Director de Política de IAPO, explora por qué la confianza debe ser el núcleo de las relaciones entre doctores y pacientes, y cómo esto debería ser un pilar fundamental de la asistencia sanitaria centrada en el paciente.

Rindiendo homenaje al lugar de nacimiento de abogacía del paciente moderna

Policy
Muchas de las estrategias de abogacía del paciente e intervenciones usadas hoy en día fueron inicialmente desarrolladas en el Distrito Castro en San Francisco, California, EEUU, en los años ochenta. Hoy en día una enorme bandera con los colores del arco iris ondea orgullosa sobre El Castro, proclamando su confianza, vitalidad y espíritu comunitario.

From collapse to case study: the Castro, birthplace of modern patient advocacy

Policy
In the 1980s, the Castro District of San Francisco was under attack from an unknown and devastating disease that was killing its young men, and attacked by the media, politicians and society that forced it to the brink of collapse.

Blogging for the British Medical Journal

Policy
Since the 7th Global Patients Congress in April, IAPO CEO Kawaldip Sehmi and Board Member Matthias Wienold have written several blogs for the world-renowned British Medical Journal.

Large-scale emergencies, health of migrants and primary care: what we said at WHA69

Policy
World Health Assembly, 23-28 May 2016. IAPO held three side meetings and addressed the Assembly on three pressing patient issues: large scale emergencies, health of migrants and primary care.

Global and local: public health and primary care in action at WHA

23 May 2016
Policy
We are hosting a side meeting at the World Health Assembly with several important organizations who speak out on behalf of patients around the world.

Putting the Patient First by Addressing Industry Practices

25 May 2016
Policy
GlaxoSmithKline (GSK) and The International Alliance of Patients’ Organizations (IAPO) are pleased to invite you a joint panel discussion on Putting the Patient First by Addressing Industry Practices.

Reaching the eyes and ears of decision-makers

Policy
Once again, the global health policy elites will meet at the 69th World Health Assembly in Geneva from 23 to 28 May 2016.

EBG Biosimilars Conference 2016

28 April 2016
Policy
Now in its 14th year, the EBG Biosimilars Conference in London has grown steadily and has become the main annual gathering of the world’s biosimilars experts.

Snakes and ladders for patients

Policy
IAPO Policy Manager Alison Lightbourne recently explored how to build a better care continuum for the Healthmanagement.org journal.

Pages

Subscribe to RSS - Policy